Leflunomide and Rashes - a phase IV clinical study of FDA data
Rashes is found among people who take Leflunomide, especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Leflunomide and have Rashes. It is created by eHealthMe based on reports of 76,285 people who have side effects when taking Leflunomide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
76,285 people reported to have side effects when taking Leflunomide.
Among them, 12,577 people (16.49%) have Rashes.
What is Leflunomide?
Leflunomide has active ingredients of leflunomide. It is often used in rheumatoid arthritis. eHealthMe is studying from 76,654 Leflunomide users for its effectiveness, alternative drugs and more.
What is Rashes?
Rashes (redness) is found to be associated with 5,196 drugs and 6,079 conditions by eHealthMe.
Number of Leflunomide and Rashes reports submitted per year:
Time on Leflunomide when people have Rashes *:
Gender of people who have Rashes when taking Leflunomide*:
Age of people who have Rashes when taking Leflunomide *:
Common drugs people take besides Leflunomide *:
Common side effects people have besides Rashes *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Leflunomide and have Rashes?Check whether Rashes is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Rashes and when was it recovered:
Expand to all the drugs that have ingredients of leflunomide:
- Rashes and drugs with ingredients of leflunomide (15,631 reports)
Alternative drugs to, pros and cons of Leflunomide:
- Leflunomide (76,654 reports)
Common Leflunomide side effects:
- Drug ineffective: 30,964 reports
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 19,759 reports
- Joint pain: 14,380 reports
- Pain: 13,190 reports
- Rashes (redness): 12,577 reports
- Joint swelling: 12,445 reports
- Fatigue (feeling of tiredness): 11,212 reports
Browse all side effects of Leflunomide:a b c d e f g h i j k l m n o p q r s t u v w x y z
Rashes treatments and more:
- Rashes (662,188 reports)
COVID vaccines that are related to Rashes:
- Rashes in Moderna COVID Vaccine
- Rashes in Pfizer BioNTech Covid Vaccine
- Rashes in Johnson and Johnson Covid Vaccine
Common drugs associated with Rashes:
- Adapalene: 49,040 reports
- Humira: 32,791 reports
- Prednisone: 31,608 reports
- Methotrexate: 30,738 reports
- Enbrel: 29,304 reports
- Aspirin: 22,501 reports
- Green tea: 21,666 reports
- Revlimid: 15,559 reports
- Pantoprazole: 15,292 reports
- Dupixent: 14,713 reports
All the drugs that are associated with Rashes:
- Rashes (5,196 drugs)
Common conditions associated with Rashes:
- Rheumatoid arthritis: 43,808 reports
- Acne: 29,888 reports
- High blood pressure: 18,830 reports
- Multiple myeloma: 18,803 reports
- Multiple sclerosis: 18,022 reports
All the conditions that are associated with Rashes:
- Rashes (6,079 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on leflunomide (the active ingredients of Leflunomide) and Leflunomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Amlodipine Besylate and Biliary Cirrhosis Primary - 3 seconds ago
- Gentamicin Sulfate and Blood Pressure Management - 7 seconds ago
- Tikosyn and Ventricular Failure - 10 seconds ago
- Tamoxifen Citrate and Osteoporosis - 16 seconds ago
- Trichlormethiazide and Hyporeflexia - 17 seconds ago
- Methimazole and Lotensin drug interaction - 19 seconds ago
- Spironolactone and Injection Site Induration - 24 seconds ago
- Timoptic and Tafluprost drug interaction - 31 seconds ago
- Buprenorphine and Meropenem drug interaction - 49 seconds ago
- Eplerenone and Right Ventricular Failure - 55 seconds ago